118 related articles for article (PubMed ID: 24568732)
1. Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation.
Noh H; Seo H
Neuroscience; 2014 Apr; 266():255-65. PubMed ID: 24568732
[TBL] [Abstract][Full Text] [Related]
2. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
Long Z; Zeng Q; Wang K; Sharma A; He G
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer's disease mice model.
Long Z; Zheng M; Zhao L; Xie P; Song C; Chu Y; Song W; He G
Curr Alzheimer Res; 2013 Mar; 10(3):261-9. PubMed ID: 23036022
[TBL] [Abstract][Full Text] [Related]
4. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
5. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
Castro LM; Gallant M; Niles LP
J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
[TBL] [Abstract][Full Text] [Related]
6. Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.
Bruno MA; Leon WC; Fragoso G; Mushynski WE; Almazan G; Cuello AC
J Neuropathol Exp Neurol; 2009 Aug; 68(8):857-69. PubMed ID: 19606067
[TBL] [Abstract][Full Text] [Related]
7. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.
Fahnestock M; Michalski B; Xu B; Coughlin MD
Mol Cell Neurosci; 2001 Aug; 18(2):210-20. PubMed ID: 11520181
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease.
Wolf SA; Kronenberg G; Lehmann K; Blankenship A; Overall R; Staufenbiel M; Kempermann G
Biol Psychiatry; 2006 Dec; 60(12):1314-23. PubMed ID: 16806094
[TBL] [Abstract][Full Text] [Related]
9. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
[TBL] [Abstract][Full Text] [Related]
10. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
Tong Z; Zhang J; Luo W; Wang W; Li F; Li H; Luo H; Lu J; Zhou J; Wan Y; He R
Neurobiol Aging; 2011 Jan; 32(1):31-41. PubMed ID: 19879019
[TBL] [Abstract][Full Text] [Related]
11. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.
Michaelis M; Suhan T; Reinisch A; Reisenauer A; Fleckenstein C; Eikel D; Gümbel H; Doerr HW; Nau H; Cinatl J
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451
[TBL] [Abstract][Full Text] [Related]
12. Brain and serum levels of nerve growth factor in a rat model of Alzheimer's disease.
Gelfo F; Tirassa P; De Bartolo P; Caltagirone C; Petrosini L; Angelucci F
J Alzheimers Dis; 2011; 25(2):213-7. PubMed ID: 21368378
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
[TBL] [Abstract][Full Text] [Related]
14. APP, NGF & the 'Sunday-driver' in a Trolley on the Road.
Heese K; Inoue N; Nagai Y; Sawada T
Restor Neurol Neurosci; 2004; 22(2):131-6. PubMed ID: 15272147
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of valproic acid following transient global ischemia in rats.
Xuan A; Long D; Li J; Ji W; Hong L; Zhang M; Zhang W
Life Sci; 2012 Mar; 90(11-12):463-8. PubMed ID: 22285595
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
18. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1 transgenic mice through improvement of hippocampal long-term potentiation.
Liu HL; Zhao G; Cai K; Zhao HH; Shi LD
Behav Brain Res; 2011 Apr; 218(2):308-14. PubMed ID: 21192984
[TBL] [Abstract][Full Text] [Related]
19. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
Hamilton A; Holscher C
Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone deacetylation enhances the neurotoxicity induced by the C-terminal fragments of amyloid precursor protein.
Kim HS; Kim EM; Kim NJ; Chang KA; Choi Y; Ahn KW; Lee JH; Kim S; Park CH; Suh YH
J Neurosci Res; 2004 Jan; 75(1):117-24. PubMed ID: 14689454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
